Michael Milburn
Articles by Michael Milburn
| 3 min read
Although many analytical chemists and biochemists will claim they have been practicing the science of identifying small molecules in biological matrices long before 2000, most agree that as a robust discovery tool, the technology is new and rapidly evolving. Since then, there has been an explosion of papers describing the technology as well as a significant number of papers using the technology for the discovery of biomarkers.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
